Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is based on the finding that tumor cells that are grown in the laboratory can be modified in such a way that, when injected to the patient, they will stimulate his/her immune response. This approach will be evaluated in patients with melanoma and colorectal, gastric, ovarian, breast, lung and kidney epithelial cancer. Tumor cells grown in the laboratory will be modified to make them stimulatory to the immune system, irradiated to kill them, and injected to the patient eight times at two-week intervals. This protocol is expected to prolong survival of metastatic cancer patients.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rozpoznanie jednego z następujących nowotworów: czerniak, rak piersi, jajnika, jelita grubego, żołądka, płuca lub nerek (w stadium rozsiewu)
- •Wiek powyżej 18 lat
- •Wcześniejsze leczenie chemioterapią, które nie przyniosło efektu
- •Dobry stan ogólny (ECOG 0-1)
- •Wystarczająca liczba neutrofili (powyżej 1000/mm³)
- •Prawidłowe parametry wątroby (ALT/AST poniżej trzykrotności normy)
- •Prawidłowa funkcja nerek (kreatynina do 1,6 mg/dl)
- •Zdolność do zrozumienia i podpisania zgody na udział w badaniu
✗ Disqualifies
- •Wiek poniżej 18 lat
- •Ciąża
- •Oczekiwana długość życia poniżej 3 miesięcy
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 2, 2025
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Hadassah Medical Organization
Jerusalem, Israel
Trial contact
Hani Steinberg, R.N. B.A.
Tamar Peretz, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.